Cargando…
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
BACKGROUND: The World Health Organization (WHO) CNS5 classification system highlights the significance of molecular biomarkers in providing meaningful prognostic and therapeutic information for gliomas. However, predicting individual patient survival remains challenging due to the lack of integrated...
Autores principales: | Ye, Liguo, Gu, Lingui, Zheng, Zhiyao, Zhang, Xin, Xing, Hao, Guo, Xiaopeng, Chen, Wenlin, Wang, Yaning, Wang, Yuekun, Liang, Tingyu, Wang, Hai, Li, Yilin, Jin, Shanmu, Shi, Yixin, Liu, Delin, Yang, Tianrui, Liu, Qianshu, Deng, Congcong, Wang, Yu, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237015/ https://www.ncbi.nlm.nih.gov/pubmed/37273702 http://dx.doi.org/10.3389/fneur.2023.1179761 |
Ejemplares similares
-
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023) -
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023) -
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023) -
Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
por: Wang, Yaning, et al.
Publicado: (2023) -
Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)